Mona Møller

1.2k total citations
7 papers, 964 citations indexed

About

Mona Møller is a scholar working on Immunology, Oncology and Biotechnology. According to data from OpenAlex, Mona Møller has authored 7 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Oncology and 3 papers in Biotechnology. Recurrent topics in Mona Møller's work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer Research and Treatments (3 papers). Mona Møller is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer Research and Treatments (3 papers). Mona Møller collaborates with scholars based in Norway, Switzerland and United Kingdom. Mona Møller's co-authors include Gustav Gaudernack, Jon Amund Eriksen, Marianne Klemp, Trond Buanes, Steinar Aamdal, Paal Brunsvig, Stephan Bernhardt, Dagmar S. Trachsel, Sissel Trachsel and Ivar P. Gladhaug and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Mona Møller

7 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mona Møller Norway	7	588	525	364	139	128	7	964
Sissel Trachsel Norway	8	412 0.7×	335 0.6×	311 0.9×	115 0.8×	122 1.0×	8	732
Beena O. Pappen United States	13	648 1.1×	417 0.8×	560 1.5×	159 1.1×	41 0.3×	19	1.1k
Walter Hanel United States	12	436 0.7×	287 0.5×	418 1.1×	54 0.4×	39 0.3×	39	910
Katherine Stephans United States	6	250 0.4×	459 0.9×	196 0.5×	54 0.4×	59 0.5×	7	702
Erik Pong United States	16	358 0.6×	484 0.9×	433 1.2×	33 0.2×	47 0.4×	24	1.1k
Daiki Fukuma Japan	18	508 0.9×	555 1.1×	500 1.4×	31 0.2×	25 0.2×	26	1.0k
P. Korkolopoulou Greece	12	243 0.4×	208 0.4×	177 0.5×	18 0.1×	132 1.0×	19	632
Gianni Am Italy	11	338 0.6×	251 0.5×	178 0.5×	40 0.3×	32 0.3×	23	863
Nan Ring United States	7	464 0.8×	782 1.5×	258 0.7×	20 0.1×	109 0.9×	12	1.1k
Jens Stanelle Germany	11	466 0.8×	274 0.5×	463 1.3×	31 0.2×	20 0.2×	13	975

Countries citing papers authored by Mona Møller

Since Specialization

Citations

This map shows the geographic impact of Mona Møller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Møller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Møller more than expected).

Fields of papers citing papers by Mona Møller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona Møller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Møller. The network helps show where Mona Møller may publish in the future.

Co-authorship network of co-authors of Mona Møller

This figure shows the co-authorship network connecting the top 25 collaborators of Mona Møller. A scholar is included among the top collaborators of Mona Møller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona Møller. Mona Møller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Brunsvig, Paal, Jon Amund Kyte, Christian Kersten, et al.. (2011). Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial. Clinical Cancer Research. 17(21). 6847–6857. 131 indexed citations

2.

Hunger, Robert E., Kristin Lang, Sissel Trachsel, et al.. (2011). Vaccination of patients with cutaneous melanoma with telomerase-specific peptides. Cancer Immunology Immunotherapy. 60(11). 1553–1564. 47 indexed citations

3.

Klemp, Marianne, Ivar P. Gladhaug, Mona Møller, et al.. (2010). Long‐term follow‐up of patients with resected pancreatic cancer following vaccination against mutant K‐ras. International Journal of Cancer. 128(5). 1120–1128. 137 indexed citations

4.

Bernhardt, Stephan, Dagmar S. Trachsel, Mona Møller, et al.. (2006). Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study. British Journal of Cancer. 95(11). 1474–1482. 238 indexed citations

5.

Brunsvig, Paal, Steinar Aamdal, Marianne Klemp, et al.. (2006). Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer. Cancer Immunology Immunotherapy. 55(12). 1553–1564. 196 indexed citations

6.

Bernhardt, Stephan, et al.. (2005). Imiquimod a new adjuvant for telomerase peptide vaccine: A phase I trial in patients with inoperable pancreatic cancer. Journal of Clinical Oncology. 23(16_suppl). 9623–9623. 6 indexed citations

7.

Sæterdal, Ingvil, Jens Bjørheim, Kari Lislerud, et al.. (2001). Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proceedings of the National Academy of Sciences. 98(23). 13255–13260. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact